—
C+
C+ The full Closelook — membership. Open the C+ overview

Medline Inc. Class A Common Stock (MDLN) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — Medline Inc. Class A Common Stock

MDLN in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Medline makes medical and surgical products used across hospitals, surgery centres, physician offices, post-acute sites and nursing homes in the United States and abroad. It runs two segments: Medline Brand, which manufactures surgical solutions, front-line patient care items and laboratory and diagnostic products, and Supply Chain Solutions, which distributes third-party brands and runs logistics and inventory services for care providers. It is based in Northfield, United States.
Where it sits in the stack
Medline holds no seat in Rubin or Halo, the diary's two build-out indices, because its products are hospital and surgical supplies rather than compute infrastructure. In our universe it sits in the Healthcare sleeve, grouped by sector and country rather than by any layer of the AI stack.
Who it is priced against
Closelook's peer group here is Healthcare names listed in the US, drawn together simply because they share sector and country: argenx, Medpace, BeiGene, Globus Medical, Regeneron, Veeva Systems, Vertex Pharmaceuticals and Corcept Therapeutics. The market also names Cardinal Health as a comparable distributor of medical supplies.
Why Closelook tracks it
Medline carries a Closelook score with valuation as its strongest module and momentum as its weakest; it holds no seat in Rubin or Halo and no quotes appear in the diary's editions yet.
What the diary watches
The diary watches whether the momentum reading recovers as the newly listed shares trade through a fuller history, and whether the valuation strength holds against that.

Medline Inc. Class A Common Stock (MDLN) trades on US exchanges.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Who it is priced against Medical Instruments & Supplies · 8 names with week and year-to-date

Peer group

Medical Instruments & Supplies

This name carries no Closelook score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against MDLN on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Dividends and capital return no distribution in twelve months · buybacks 2.00 bn USD in FY2025

Dividends and capital return

What MDLN pays out and buys back — distributions read from the price series, money terms from the filings.

  • Distributions No cash distribution recorded in the price series over the last three years
  • Buybacks, FY2025 2.00 bn USD 4.7% of today's market value
  • Share count +3.2% in FY2025 76 m USD of stock-based compensation in the year
  • Capital returned 2.00 bn USD · 154% of free cash flow dividends and buybacks together, against the year’s free cash flow

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 66/100 · S&P 500 fund at 64, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-22
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 99th percentile of the window, +10.8% over 20 sessions. Factor regime → 2026-09-22
  • Sovereign pressure Index -0.03 · down 0.40 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-22

FAQ · from the current data · as of 2026-09-23

Quick answers

What is Medline Inc. Class A Common Stock (MDLN)?

Medline Inc. Class A Common Stock trades as MDLN on the US exchange (US) in the Closelook research universe, as of the registry build of 2026-09-23.

Is MDLN in a Closelook index?

Not currently — Medline Inc. Class A Common Stock is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-23.

What does Medline Inc. Class A Common Stock do?

Medline makes medical and surgical products used across hospitals, surgery centres, physician offices, post-acute sites and nursing homes in the United States and abroad. It runs two segments: Medline Brand, which manufactures surgical solutions, front-line patient care items and laboratory and diagnostic products, and Supply Chain Solutions, which distributes third-party brands and runs logistics and inventory services for care providers. It is based in Northfield, United States. Closelook's peer group here is Healthcare names listed in the US, drawn together simply because they share sector and country: argenx, Medpace, BeiGene, Globus Medical, Regeneron, Veeva Systems, Vertex Pharmaceuticals and Corcept Therapeutics. The market also names Cardinal Health as a comparable distributor of medical supplies.

Where does Medline Inc. Class A Common Stock sit in the AI build-out?

Medline holds no seat in Rubin or Halo, the diary's two build-out indices, because its products are hospital and surgical supplies rather than compute infrastructure. In our universe it sits in the Healthcare sleeve, grouped by sector and country rather than by any layer of the AI stack. Medline carries a Closelook score with valuation as its strongest module and momentum as its weakest; it holds no seat in Rubin or Halo and no quotes appear in the diary's editions yet.

Does Medline Inc. Class A Common Stock pay a dividend?

No cash distribution shows in Medline Inc. Class A Common Stock’s price series over the last three years. In fiscal 2025 the company bought back 2.00 bn USD of its own shares, 154% of that year’s free cash flow. The share count rose 3.2% over the fiscal year. The "Dividends and capital return" block on this page carries the lines.

What does this page show?

A live price chart with SMA overlays and drawing tools for MDLN, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe

then Medical Instruments & Supplies. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.